Abstract
Extraocular muscle enlargement can occur secondary to a range of orbital and systemic diseases. Although the most common cause of extraocular muscle enlargement is thyroid eye disease, a range of other inflammatory, infective, neoplastic, and vascular conditions can alter the size and shape of the extraocular muscles. Imaging with computed tomography and magnetic resonance imaging plays an essential role in the workup of these conditions. This article provides an image-rich review of the wide range of pathology that can cause enlargement of the extraocular muscles.
Keywords: Extraocular muscle, Computed tomography, Magnetic resonance imaging, Orbit
Introduction
Extraocular muscle enlargement (EOME) can occur secondary to an array of inflammatory, neoplastic, infective or vascular conditions. Orbital imaging with computed tomography (CT) or magnetic resonance imaging (MRI) plays an essential role in the workup of these conditions. High-resolution orbital MRI has allowed for a more detailed characterisation of orbital disease. Recognising the pattern of muscle involvement along with accompanying orbital signs can help to narrow the differential diagnosis, or even enable a single diagnosis. This review focuses on the radiological findings associated with pathology that cause extraocular muscle enlargement.
Thyroid eye disease
Thyroid eye disease (TED) is the most common inflammatory myopathy affecting the extraocular muscles. Radiologically, it presents with bilateral enlargement of the muscle belly with relative sparing of the anterior tendon. Traditionally, muscles are said to be involved in the following order: inferior rectus, medial rectus, superior rectus and lateral rectus (Fig. 1A) [1]. However, it is now being recognised that superior muscle complex involvement is also very frequent, possibly the most common [2, 3]. Furthermore, isolated levator muscle enlargement can also occur (Fig. 1B) and is associated with upper eyelid retraction [2–4]. Both superior and inferior oblique involvement has also been recognised and should be assessed on imaging (Fig. 1C, D) [5, 6].
Most patients with TED have muscle enlargement. However, up to one-fourth of patients will have no fat or muscle enlargement, and a smaller proportion will only have fat expansion without muscle enlargement [7]. TED can also be accompanied by bilateral, unilateral or asymmetric lacrimal gland enlargement [8, 9].
TED is a clinical diagnosis. Imaging can assist in differentiating TED from alternative pathologies in unclear cases, identify active orbital inflammation, predict response to therapy and assist in diagnosing dysthyroid optic neuropathy.
Dysthyroid optic neuropathy
Dysthyroid optic neuropathy (DON) is a sight-threatening complication of TED. A number of radiological features can assist in diagnosing DON: orbital apex crowding [10], higher extraocular muscle volumes [11], superior ophthalmic vein enlargement [12], effacement of the fat plane surrounding the optic nerve [13], anterior displacement of the lacrimal gland [13], enlarged tendons [14] and superior orbital fissure fat prolapse [15]. It should be noted that DON is essentially a clinical diagnosis of exclusion and absence of the aforementioned radiological signs does not preclude the diagnosis.
A muscle index of greater than 50%, defined as the percentage of orbital height occupied by the superior and inferior recti or percentage of width occupied by the horizontal recti at the midpoint between the posterior globe and orbital apex, has a high sensitivity for DON (Fig. 2) [15, 16]. The anatomy of the bony orbit can also predispose patients to the development of DON. Patients with DON have shown to have narrower bony orbital angles than patients without DON for an identical muscle diameter index [10].
Enlargement of the superior muscle complex plays an important role in the development of DON [17, 18]. This correlates clinically with the inferior visual field deficits seen in TED. The ratio of the superior rectus-levator complex volume to the summated soft tissue volume is significantly higher in patients with DON, whereas no significant differences have been observed for the other extraocular muscles [18]. Anatomically, this may be explained by the fact that the superior rectus narrows vertically less than the inferior rectus as it approaches the annulus of Zinn.
Active thyroid eye disease
Various imaging techniques have been used to assess orbital inflammation to help diagnose active disease and predict response to therapy. Active TED involves inflammatory oedema of the extraocular muscles which corresponds to T2-hyperintensity and increased contrast enhancement relative to unaffected extraocular muscles (Fig. 3) [19, 20]. This is in comparison to the findings seen in a normal patient (Fig. 4) with no T2-hyperintensity of the extraocular muscles, no significant or asymmetric extraocular muscle enhancement and no hyperintense signals on ADC map.
Signal intensity ratio
A higher signal intensity ratio (SIR), the ratio of signal intensity from the extraocular muscles to the signal intensity of normal tissue (e.g. brain white matter), is a marker of active TED and has shown correlation with the clinical activity score [21–23]. The SIR can be measured on STIR and T2-weighted sequences (Fig. 5) [19, 21–24]. The SIR usually decreases following immunosuppressive therapy or radiotherapy [25, 26]. Patients with persistently high SIRs despite medical therapy may be at an increased risk of further clinical deterioration [25].
Apparent diffusion coefficient
Diffusion-weighted imaging and the corresponding apparent diffusion coefficient (ADC) values can quantitatively and qualitatively assess the diffusion of water at a cellular level. Higher ADC values are seen in the acute inflammatory phase of TED and can help differentiate the active phase of TED from the inactive fibrotic phase (Fig. 3D) [27]. Hyperintense ADC signal within the extraocular muscles may be seen prior to any abnormality being seen on conventional MRI [28]. This may allow for earlier initiation of medical therapies in these patients. Additionally, ADC values can also help to monitor treatment response as they have shown correlation with the CAS and decrease following steroid therapy [27].
T2 relaxation time
T2 relaxation time (T2RT) is a tissue-specific time constant describing the decay of transverse magnetisation of tissues. Accordingly, changes within the cellular architecture of extraocular muscles can be quantitatively assessed with T2RTs. Patients with active TED have higher T2RT than inactive TED or healthy controls, and the T2RT has been correlated with the CAS and muscle areas [29–31]. A higher pre-intervention T2RT may be used to predict patients who are less likely to response to steroid therapy [32]. T2RT decreases following steroid therapy and can also be used to monitor the patient’s response to steroid therapy [30, 33].
Inactive thyroid eye disease
Inactive TED is characterised by interstitial fibrosis, collagen deposition and fatty infiltration. Fatty infiltration can be seen as areas of hypodensity within the extraocular muscles on computed tomography and is significantly more common in patients with TED as compared to healthy controls [34]. Heterogenous areas of low signal intensity within the extraocular muscles on T2-weighted imaging may represent areas of fibrotic change and is more common in patients with irreversible diplopia following medical therapy [24].
Other inflammatory conditions
Myositis of the extraocular muscles can be secondary to idiopathic orbital myositis or a range of specific autoimmune conditions. McNab [35] has proposed a comprehensive classification system for orbital myositis focused on defining the underlying aetiology of the myositis.
Idiopathic orbital myositis
Idiopathic orbital myositis is a subset of idiopathic orbital inflammatory syndrome or orbital pseudotumor. Idiopathic orbital myositis commonly presents unilaterally with single muscle involvement (Fig. 6) [36–38]. The medial or lateral recti are most commonly involved [39, 40]. Enlargement of the anterior muscle tendon can help differentiate it from TED; however, this is only seen in approximately half of all cases and in approximately 6% of TED patients [37, 38, 41, 42]. Orbital fat infiltration and lacrimal gland involvement can also be observed [43–45]. Multiple and bilateral muscle involvement and muscle tendon sparing are risk factors for recurrent disease [38, 46]. On MRI, the affected muscles are isointense on T1 and hyperintense on T2-weighted imaging [47–49].
Specific myositis
IgG4-related disease
IgG4-related disease (IgG4-RD) is a multisystemic inflammatory disease of unknown aetiology. IgG4-related ophthalmic disease (IgG4-ROD) is being increasingly recognised as a cause of previously labelled idiopathic orbital inflammation [50]. Bilateral enlargement of multiple muscles, particular the lateral rectus, is common (Fig. 7). This is usually accompanied by a combination of lacrimal gland enlargement, infraorbital or frontal nerve enlargement, sinus mucosal thickening, and pterygopalatine fossa involvement [51–54]. Trigeminal pathway involvement is a useful diagnostic sign for IgG4-ROD with one study finding that 50% of patients with infraorbital nerve enlargement had IgG4-ROD [55]. On CT, the muscles are isodense compared to unaffected muscles and on MRI muscles are isointense on T1 and hypoisointense lesions on T2 imaging are seen [53, 54, 56].
Inflammatory bowel disease
Inflammatory bowel disease (IBD) consisting of ulcerative colitis and Crohn’s disease has been associated with orbital myositis. Presentation can be unilateral or bilateral with the medial and inferior recti most commonly involved [57–59]. Compared to idiopathic orbital myositis, bilateral muscle involvement is more common in the IBD group [35]. Fusiform enlargement of muscles with tendon sparing can mimic the presentation of TED [57, 59, 60]. The past medical history, thyroid hormone, and antibody studies can help make the distinction in such cases. The muscles can be large enough to cause optic nerve compression [57]. On MRI, the muscles are isointense on T1 and hyperintense on T2-weighted imaging [58, 60, 61].
Sarcoidosis
The most common ocular presentation of sarcoidosis is with anterior uveitis with orbital myositis being relatively infrequent [62]. When affecting the muscles, bilateral disease with multiple muscle involvement and anterior tendon involvement is commonly seen [36, 63–66]. Involvement of surrounding structures can include the lacrimal gland, lateral wall of the cavernous sinus, and thickening and encasement of optic nerve producing a ‘tram-track’ sign [64, 67, 68]. The affected muscles are isointense on T1 and hypo-isointense on T2 with potential areas of higher intensity nodules [66–68].
Granulomatosis with polyangiitis
Granulomatosis with polyangiitis (GPA) is a multisystemic autoimmune disorder characterised by necrotising granulomatous inflammation. Orbital involvement occurs in up to 50% of GPA patients usually presenting with an orbital mass, or dacryoadenitis with isolated extraocular myositis being uncommon [69]. Concomitant sinus and nasal disease is common. Pachymeningeal enhancement may occur [70]. Extraocular myositis usually presents unilaterally with fusiform muscle enlargement and tendon sparing (Fig. 8) [36, 71–73]. Unilateral or bilateral involvement is possible [74–76]. The affected muscles are isointense on T1 [72]. Areas of hypoenhancement following contrast administration representing zonal necrosis may be suggestive of GPA [73]. On T2, a high signal intensity with a rim of hypointensity may also represent intralesional necrosis suggestive of GPA [71].
A range of other autoimmune conditions can be associated with orbital myositis including systemic/discoid lupus erythematosus [77, 78], giant-cell myositis [79–82], rheumatoid arthritis [83] and psoriasis [84]. Orbital myositis can occur secondary to drug reactions from the newer monoclonal antibodies, bisphosphonates or statins [35]. The pattern of enlargement is similar to idiopathic orbital myositis, with the muscles showing T1 isointensity and T2 hyperintensity.
Neoplastic conditions
A number of tumours can metastasise to the orbit causing extraocular muscle enlargement. Uncommonly, EOME may be the initial manifestation of a previously undiagnosed tumour [85].
Lymphoma
Orbital lymphoma is the most common malignant tumour of the orbit in adults [86]. Intramuscular involvement is uncommon [87]. Extraocular muscle lymphoma presents unilaterally with either fusiform muscle enlargement and tendon sparing or diffuse muscle enlargement with tendon involvement (Fig. 9) [88–93]. Lymphoma is hypoisointense on T1 and iso to hyperintense on T2 imaging [75, 89, 94–96]. The presence of an orbital mass or lacrimal gland involvement that moulds to the globe or bone can help aid the diagnosis of lymphoma [89, 97–102].
Breast cancer
Breast cancer is one of the most common primary tumours to metastasise to the orbit [75, 103]. Breast cancer may present with unilateral [95, 104, 105] or bilateral extraocular muscle involvement (Fig. 10A, B) [106–108]. The horizontal recti are most commonly involved; however, involvement of the obliques has also been reported [85, 105, 108]. It commonly presents with fusiform muscle enlargement of affected muscles with tendon sparing [85, 108–112]. On MRI, the lesion is iso-hyperintense on T1- and T2-weighted imaging (Fig. 10C, D) [95, 104, 110, 113] with homogenous contrast enhancement [105, 112, 114].
Melanoma
Melanoma most commonly involves the medial rectus muscle [95, 115–117]. Well-defined focal nodular enlargement of muscles without involvement of the anterior tendon is most common [115, 116, 118]. On CT, the affected muscles are isodense compared to unaffected muscles. On MRI, the lesion is iso-hyperintense on T1 and hypo-isointense on T2 imaging. Heterogenous contrast enhancement with areas of central hypointensity reflecting haemorrhage, and increased peripheral rim enhancement can be seen (Fig. 11) [111, 115, 119]. Atypical presentations showing cystic masses with fluid–fluid levels have also been reported [118].
Neuroendocrine tumour
Neuroendocrine tumours originate from the enterochromaffin cells of the gastrointestinal tract or bronchial lining. Unilateral presentation is most common with involvement of any of the extraocular muscles including the obliques [120–122]. Well-defined focal intramuscular masses are seen on imaging [95, 120, 122–125]. The masses may be of a significant size causing compression of adjacent structures including the optic nerve [95, 124–126]. They are isointense on T1 and hypo-isointense on T2-weighted imaging [95, 123, 127]. Heterogenous contrast enhancement can be seen [122, 124, 128]. Intralesional haemorrhage may be seen as ovoid areas of low signal intensity following contrast administration (Fig. 12) [129, 130].
Gastric adenocarcinoma
Gastric adenocarcinoma presents with diffuse muscle enlargement [117, 131, 132]. Nodular and fusiform enlargement of muscles has also been reported [133, 134]. The diffuse enlargement may involve the anterior muscle tendon [132]. Gastric adenocarcinoma appears isointense on T1 and iso-hyperintense on T2-weighted imaging [131, 134].
Amyloidosis
Amyloidosis is a multisystemic disease with deposition of amyloid protein occurring in various parts of the body. Amyloidosis can uncommonly infiltrate the extraocular muscles presenting with unilateral or bilateral involvement of the extraocular muscles [135–137]. The horizontal recti are most commonly involved [138]. It usually causes tendon sparing fusiform enlargement of the affected muscles [138–142] and can mimic TED particularly when it involves the inferior or medial recti [142, 143]. Calcified lesions infiltrating the extraocular muscles can however be seen on CT helping to differentiate it from TED [139, 142]. Adjacent hyperostosis and bony irregularity can support a diagnosis of amyloidosis [144]. On T1-weighted imaging, the enlarged muscles are isointense to the extraocular muscles [137, 139, 141]. On T2-weighted imaging, hypointense lesions can be seen reflecting the amyloid involvement (Fig. 13) [135, 139]. Contrast-enhanced scans may reveal heterogenous enhancement with patchy areas of reduced enhancement [135, 140, 141].
Vascular conditions
Vascular malformations can cause extraocular muscle enlargement. Arteriovenous malformations cause an increase in pressure within the cavernous sinus resulting in decreased venous outflow from the superior ophthalmic vein. The resultant elevated capillary pressure causes enlargement of the extraocular muscles.
Primary vascular malformations of the orbit can also lead to extraocular muscle enlargement by direct infiltration of the muscles, arteriovenous shunting or haemorrhage within the muscles. This is a separate section later anyway. Intraorbital arteriovenous malformations or AV malformations secondary to retinoencephalofacial angiomatosis or facial angiomatosis have also been reported to cause EOME [145–147].
Carotid-cavernous fistula
The description of the pattern of muscle enlargement in patients with carotid-cavernous fistulas (CCF) is limited in the literature. Accompanying radiological signs can often help aid the diagnosis. These signs include a dilatation of the superior ophthalmic vein which is seen in more than 80% of CCF cases (Fig. 14A) [46, 147, 148]. Other supportive findings include internal signal void within the cavernous sinus, and prominent venous drainage in the anterior, posterior or lateral venous sinuses [149]. Unilateral enlargement of multiple extraocular muscles can occur (Fig. 14B, C). Enlargement of the extraocular muscles will generally involve all the muscles on the affected side and may be accompanied by intraconal fat stranding [149]. Expansion and bulging of the lateral wall of the cavernous sinus is more prominent on the fistula side [148, 150]. If the intercommunicating vessels within the cavernous sinus are large enough, there may be bilateral expansion of the cavernous sinuses and involvement of both eyes [148].
Spontaneous haemorrhage related to the extraocular muscles
Nontraumatic orbital haemorrhage within the extraocular muscle belly or related to the muscle sheath can occur spontaneously in the absence of underlying vascular malformations. It usually presents in older females often with a history of hypertension and hyperlipidaemia [151]. Intra/juxtamuscular haemorrhage has a distinct radiological appearance which can help make the diagnosis and prevent unnecessary further investigations.
Intramuscular haemorrhage most commonly presents with unilateral involvement of the inferior rectus muscle [151, 152]. A large, often well-defined mass with an anterior rounded border and posterior tapering edge towards the orbital apex (“tear drop” appearance on axial scans and “beached whale” appearance on sagittal when involving the inferior rectus) is characteristic (Fig. 15) [151]. On CT, the haematoma is hyperdense if acute and hypo-isodense if subacute [153]. A fluid level may be observed in the clot, further supporting a diagnosis of a haematoma [152, 154]. Haemorrhage on MRI has a variable appearance depending on the age of the blood, stages of the clot and MRI sequence used. A fresh clot with deoxyhaemoglobin (< 2 days) is isointense on T1 and hypointense on T2W-MRI [153]. As the clot changes to intracellular methemoglobin, the signal on T1W-MRI becomes hyperintense and hypointense on T2W-MRI [153]. Extracellular methemoglobin is hyperintense on T2 and is seen between 2 weeks and 2 months after the initial haemorrhage. Serial MRIs can help to identify these changes and support the diagnosis of an intramuscular haemorrhage. Although gradient sequences are distorted at the level of the orbit, some sequences such as the B0 of the diffusion sequence may demonstrate low signal in the acute phase (susceptibility artefact) suggesting haemorrhage.
Infective conditions
Cysticercosis
Cysticercosis is a parasitic infection caused by Cysticercus cellulosae, which is endemic in regions with poor sanitation. Orbital or extraocular muscle cysticercosis most commonly presents in teenagers [155, 156]. Extraocular muscle cysticercosis presents unilaterally with single muscle involvement of any of the extraocular muscles including the obliques [155]. Rath, Honavar, Naik, Anand, Agarwal, Krishnaiah and Sekhar [156] reviewed 138 cases of extraocular muscle cysticercosis and reported the superior rectus muscle to be most commonly involved, followed by the inferior, medial and lateral recti in descending order. On CT, imaging reveals an intramuscular hypodense, ring enhancing cystic lesion (Fig. 16), often in association with a scolex in approximately 50% of cases [156–158]. On T2-weighted imaging, a round hyperintense nodule can be seen on a hypointense background [159, 160] and on T1-fat-suppressed post contrast, a ring enhancing lesion with a hypointense central nodule is typical [161, 162].
Hydatid cyst
Hydatid cysts result from infection with the parasite Echinococus granulosus and can result in cyst formation anywhere in the body. Extraocular muscle hydatid cysts are rare. On MRI, it presents as a multiloculated cystic lesion which is hypointense on T1 and demonstrates peripheral rim enhancement following contrast administration [163].
Pyomyositis
Pyomyositis is an acute bacterial infection of skeletal muscle, usually caused by Staphylococcus aureus. It has a characteristic appearance on imaging. It presents unilaterally with involvement of any of the extraocular muscles. On CT, a round-oval hypodense lesion with rim enhancement is characteristically observed [164–166]. On T1-weighted imaging, a hypointense central lesion with rim enhancement can be seen, alongside oedema and enlargement of the affected muscle [166–168]. An abscess within the muscle usually results in restricted diffusion.
Orbital cellulitis
Orbital cellulitis most commonly occurs from direct extension of adjacent sinus infection or preseptal cellulitis and imaging may reveal inflammation in these adjacent areas. Any of the extraocular muscles can be enlarged in orbital cellulitis (Fig. 17) [169]. Associated features include intraconal fat stranding, dacryoadenitis and optic perineuritis [170]. Potential complications include orbital abscess formation, intracranial extension and cavernous sinus thrombosis [170, 171].
Conclusion
Extraocular muscle enlargement is most commonly due to thyroid eye disease; however, it can occur secondary to a number of other inflammatory, vascular or neoplastic conditions. Imaging is playing an increasingly important role in the characterisation of orbital diseases and can aid the diagnosis and management of orbital conditions. Ultimately, the diagnosis will be made in conjunction with an understanding of the patient’s demographics, past medical history and presentation. In cases where there is diagnostic uncertainty, an orbital biopsy may be required for definitive diagnosis.
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions
Declarations
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Enzmann DR, Donaldson SS, Kriss JP. Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr. 1979;3:815–819. doi: 10.1097/00004728-197903060-00019. [DOI] [PubMed] [Google Scholar]
- 2.Davies MJ, Dolman PJ. Levator Muscle Enlargement in Thyroid Eye Disease-Related Upper Eyelid Retraction. Ophthalmic Plast Reconstr Surg. 2017;33:35–39. doi: 10.1097/iop.0000000000000633. [DOI] [PubMed] [Google Scholar]
- 3.Wang Y, Mettu P, Broadbent T, Radke P, Firl K, Shepherd JB, Couch SM, 3rd, Nguyen A, Henderson AD, McCulley T, McClelland CM, Mokhtarzadeh A, Lee JA, Garrity MS, Harrison AR. Thyroid eye disease presenting with superior rectus/levator complex enlargement. Orbit. 2020;39:5–12. doi: 10.1080/01676830.2019.1594969. [DOI] [PubMed] [Google Scholar]
- 4.Kozaki A, Inoue R, Ito G, Mizuno K, Inoue T. Features of untreated Graves' disease patients with bilateral upper eyelid retraction. Invest Ophthalmol Vis Sci. 2014;55:4102. [Google Scholar]
- 5.Thacker NM, Velez FG, Demer JL, Rosenbaum AL. Superior oblique muscle involvement in thyroid ophthalmopathy. J aapos. 2005;9:174–178. doi: 10.1016/j.jaapos.2004.12.005. [DOI] [PubMed] [Google Scholar]
- 6.Kakizaki H, Zako M, Iwaki M. Thyroid-associated inferior oblique myopathy. Ophthalmology. 2007;114:2106. doi: 10.1016/j.ophtha.2007.04.034. [DOI] [PubMed] [Google Scholar]
- 7.Regensburg NI, Wiersinga WM, Berendschot TT, Potgieser P, Mourits MP. Do subtypes of graves' orbitopathy exist? Ophthalmology. 2011;118:191–196. doi: 10.1016/j.ophtha.2010.04.004. [DOI] [PubMed] [Google Scholar]
- 8.Bingham CM, Harris MA, Realini T, Nguyen J, Hogg JP, Sivak-Callcott JA. Calculated computed tomography volumes of lacrimal glands and comparison to clinical findings in patients with thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2014;30:116–118. doi: 10.1097/iop.0000000000000015. [DOI] [PubMed] [Google Scholar]
- 9.Harris MA, Realini T, Hogg JP, Sivak-Callcott JA. CT dimensions of the lacrimal gland in Graves orbitopathy. Ophthalmic Plast Reconstr Surg. 2012;28:69–72. doi: 10.1097/IOP.0b013e31823c4a3a. [DOI] [PubMed] [Google Scholar]
- 10.Chan LL, Tan HE, Fook-Chong S, Teo TH, Lim LH, Seah LL. Graves ophthalmopathy the bony orbit in optic neuropathy, its apical angular capacity and impact on prediction of risk. AJNR Am J Neuroradiol. 2009;30:597–602. doi: 10.3174/ajnr.A1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gonçalves AC, Silva LN, Gebrim EM, Matayoshi S, Monteiro ML. Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures. Clinics (Sao Paulo) 2012;67:891–896. doi: 10.6061/clinics/2012(08)06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lima Bda R, Perry JD. Superior ophthalmic vein enlargement and increased muscle index in dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg. 2013;29:147–149. doi: 10.1097/IOP.0b013e3182831bd8. [DOI] [PubMed] [Google Scholar]
- 13.Maj E, Cieszanowski A, Miskiewicz P, Trautsolt K, Bednarczuk T, Samsel A, Krzeski A, Rowinski O. The value of MR imaging for the diagnosis of optic nerve neuropathy in patients with graves' disease. Neuroradiology. 2013;55:S85–S86. doi: 10.1007/s00234-013-1236-8. [DOI] [Google Scholar]
- 14.Weis E, Heran MK, Jhamb A, Chan AK, Chiu JP, Hurley MC, Rootman J. Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: refinement of the constellation of findings at presentation. Arch Ophthalmol. 2011;129:1332–1336. doi: 10.1001/archophthalmol.2011.276. [DOI] [PubMed] [Google Scholar]
- 15.Giaconi JA, Kazim M, Rho T, Pfaff C. CT scan evidence of dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg. 2002;18:177–182. doi: 10.1097/00002341-200205000-00005. [DOI] [PubMed] [Google Scholar]
- 16.So NM, Lam WW, Cheng G, Metreweli C, Lam D. Assessment of optic nerve compression in Graves' ophthalmopathy The usefulness of a quick T1-weighted sequence. Acta Radiol. 2000;41:559–561. doi: 10.1080/028418500127346207. [DOI] [PubMed] [Google Scholar]
- 17.Starks VS, Reinshagen KL, Lee NG, Freitag SK. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease. Orbit. 2020;39:77–83. doi: 10.1080/01676830.2019.1600150. [DOI] [PubMed] [Google Scholar]
- 18.Oropesa S, Dunbar KE, Godfrey KJ, Callahan AB, Campbell AA, Kazim M. Predominant contribution of superior rectus-levator complex enlargement to optic neuropathy and inferior visual field defects in thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2019;35:262–265. doi: 10.1097/iop.0000000000001224. [DOI] [PubMed] [Google Scholar]
- 19.Liu X, Su Y, Jiang M, Fang S, Huang Y, Li Y, Zhong S, Wang Y, Zhang S, Wu Y, Sun J, Fan X, Zhou H. Application of magnetic resonance imaging in the evaluation of disease activity in Graves' ophthalmopathy. Endocr Pract. 2021;27:198–205. doi: 10.1016/j.eprac.2020.09.008. [DOI] [PubMed] [Google Scholar]
- 20.Cakirer S, Cakirer D, Basak M, Durmaz S, Altuntas Y, Yigit U. Evaluation of extraocular muscles in the edematous phase of Graves ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. J Comput Assist Tomogr. 2004;28:80–86. doi: 10.1097/00004728-200401000-00013. [DOI] [PubMed] [Google Scholar]
- 21.Higashiyama T, Iwasa M, Ohji M. Quantitative analysis of inflammation in orbital fat of thyroid-associated ophthalmopathy using MRI signal intensity. Sci Rep. 2017;7:16874. doi: 10.1038/s41598-017-17257-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mayer E, Herdman G, Burnett C, Kabala J, Goddard P, Potts MJ. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease. Eye (Lond) 2001;15:313–318. doi: 10.1038/eye.2001.102. [DOI] [PubMed] [Google Scholar]
- 23.Mayer EJ, Fox DL, Herdman G, Hsuan J, Kabala J, Goddard P, Potts MJ, Lee RW. Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. Eur J Radiol. 2005;56:20–24. doi: 10.1016/j.ejrad.2005.03.027. [DOI] [PubMed] [Google Scholar]
- 24.Yokoyama N, Nagataki S, Uetani M, Ashizawa K, Eguchi K. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Thyroid. 2002;12:223–227. doi: 10.1089/105072502753600179. [DOI] [PubMed] [Google Scholar]
- 25.Higashiyama T, Nishida Y, Morino K, Ugi S, Nishio Y, Maegawa H, Ohji M. Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy. Jpn J Ophthalmol. 2015;59:124–130. doi: 10.1007/s10384-014-0365-x. [DOI] [PubMed] [Google Scholar]
- 26.Wu Y, Tong B, Luo Y, Xie G, Xiong W. Effect of radiotherapy on moderate and severe thyroid associated ophthalmopathy: a double blind and self-controlled study. Int J Clin Exp Med. 2015;8:2086–2096. [PMC free article] [PubMed] [Google Scholar]
- 27.Feeney C, Lingam RK, Lee V, Rahman F, Nagendran S (2020) Non-EPI-DWI for detection, disease monitoring, and clinical decision-making in thyroid eye disease. AJNR Am J Neuroradiol 41:1466-1472. 10.3174/ajnr.A6664 [DOI] [PMC free article] [PubMed]
- 28.Kilicarslan R, Alkan A, Ilhan MM, Yetis H, Aralasmak A, Tasan E. Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease. Br J Radiol. 2015;88:20140677. doi: 10.1259/bjr.20140677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Chen W, Hu H, Chen HH, Su GY, Yang T, Xu XQ, Wu FY. Utility of T2 mapping in the staging of thyroid-associated ophthalmopathy: efficiency of region of interest selection methods. Acta Radiol. 2020;61:1512–1519. doi: 10.1177/0284185120905032. [DOI] [PubMed] [Google Scholar]
- 30.He Y, Mu K, Liu R, Zhang J, Xiang N. Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial. Endocr J. 2017;64:141–149. doi: 10.1507/endocrj.EJ16-0083. [DOI] [PubMed] [Google Scholar]
- 31.Hou K, Ai T, Hu WK, Luo B, Wu YP, Liu R. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy. J Huazhong Univ Sci Technolog Med Sci. 2017;37:938–942. doi: 10.1007/s11596-017-1831-8. [DOI] [PubMed] [Google Scholar]
- 32.Liu P, Luo B, Chen L, Wang QX, Yuan G, Jiang GH, Zhang J. Baseline volumetric T2 relaxation time histogram analysis: can it be used to predict the response to intravenous methylprednisolone therapy in patients with thyroid-associated ophthalmopathy? Front Endocrinol (Lausanne) 2021;12:614536. doi: 10.3389/fendo.2021.614536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Utech CI, Khatibnia U, Winter PF, Wulle KG. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. Thyroid. 1995;5:185–193. doi: 10.1089/thy.1995.5.185. [DOI] [PubMed] [Google Scholar]
- 34.Cohen LM, Liou VD, Cunnane ME, Yoon MK (2020) Radiographic analysis of fatty infiltration of the extraocular muscles in thyroid eye disease. Orbit: 1–6. 10.1080/01676830.2020.1817100 [DOI] [PubMed]
- 35.McNab AA. Orbital myositis: a comprehensive review and reclassification. Ophthalmic Plast Reconstr Surg. 2020;36:109–117. doi: 10.1097/iop.0000000000001429. [DOI] [PubMed] [Google Scholar]
- 36.Savino G, Midena G, Tartaglione T, Milonia L, Caputo CG, Grimaldi G. Clinical-radiological patterns and histopathological outcomes in non-thyroid extraocular muscle enlargement: retrospective case series and current concepts. Ophthalmic Plastic Reconstructive Surg. 2020;36:284–291. doi: 10.1097/IOP.0000000000001533. [DOI] [PubMed] [Google Scholar]
- 37.Mombaerts I, Koornneef L. Current status in the treatment of orbital myositis. Ophthalmology. 1997;104:402–408. doi: 10.1016/s0161-6420(97)30301-7. [DOI] [PubMed] [Google Scholar]
- 38.Mannor GE, Rose GE, Moseley IF, Wright JE 1997 Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology 104: 409–413; discussion, 414. 10.1016/s0161-6420(97)30300-5 [DOI] [PubMed]
- 39.MS Kang HK Yang N Kim JM Hwang 2020 Clinical features of ocular motility in idiopathic orbital myositis J Clin Med 9. 10.3390/jcm9041165 [DOI] [PMC free article] [PubMed]
- 40.Dresner SC, Rothfus WE, Slamovits TL. Computed tomography of orbital myositis. American J Roentgenology. 1984;143:671–674. doi: 10.2214/ajr.143.3.671. [DOI] [PubMed] [Google Scholar]
- 41.Jakobiec FA, Syed ZA, Stagner AM, Harris GJ, Rootman J, Yoon MK, Mombaerts I. Orbital inflammation in pregnant women. Am J Ophthalmol. 2016;166:91–102. doi: 10.1016/j.ajo.2016.03.029. [DOI] [PubMed] [Google Scholar]
- 42.Ben Simon GJ, Syed HM, Douglas R, McCann JD, Goldberg RA. Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy. Am J Ophthalmol. 2004;137:1145–1147. doi: 10.1016/j.ajo.2004.01.033. [DOI] [PubMed] [Google Scholar]
- 43.Yawar B, Malik Z, Naz F. A rare case of orbital myositis. J Ayub Med Coll Abbottabad. 2020;32(Suppl 1):S706–s708. [PubMed] [Google Scholar]
- 44.Kang MS, Yang HK, Kim N, Hwang JM (2020) Clinical features of ocular motility in idiopathic orbital myositis. J Clin Med 9. 10.3390/jcm9041165 [DOI] [PMC free article] [PubMed]
- 45.Weber AL, Romo LV, Sabates NR. Pseudotumor of the orbit: clinical, pathologic, and radiologic evaluation. Radiologic Clin North America. 1999;37:151–168. doi: 10.1016/S0033-8389(05)70084-1. [DOI] [PubMed] [Google Scholar]
- 46.Lacey B, Chang W, Rootman J. Nonthyroid causes of extraocular muscle disease. Survey Ophthalmol. 1999;44:187–213. doi: 10.1016/S0039-6257(99)00101-0. [DOI] [PubMed] [Google Scholar]
- 47.Douglas VP, Douglas KAA, Rizzo JF, 3rd, Chwalisz BK. Case report: Orbital myositis triggering oxygen-responsive cluster headache. Cephalalgia. 2020;40:313–316. doi: 10.1177/0333102419865974. [DOI] [PubMed] [Google Scholar]
- 48.Hattori H, Ohnishi S, Nakagawa Y, Ikemiya M, Yamato K, Matsuoka O, Yokoyama T, Yamano T. An infant with idiopathic orbital myositis poorly responsive to steroid therapy: A case report. Brain and Development. 2005;27:160–162. doi: 10.1016/j.braindev.2004.05.002. [DOI] [PubMed] [Google Scholar]
- 49.Zheng Y, Zhang YX, Ding MP. Treatment of idiopathic orbital myositis with frequent relapses: first case with tacrolimus and review of literature. J Neuroimmunol. 2020;346:577316. doi: 10.1016/j.jneuroim.2020.577316. [DOI] [PubMed] [Google Scholar]
- 50.Wu NA, Sun FY. Clinical observation of orbital IgG4-related disease. Experiment Therapeutic Med. 2019;17:883–887. doi: 10.3892/etm.2018.7002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Wallace ZS, Khosroshahi A, Jakobiec FA, Deshpande V, Hatton MP, Ritter J, Ferry JA, Stone JH. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012;57:26–33. doi: 10.1016/j.survophthal.2011.07.004. [DOI] [PubMed] [Google Scholar]
- 52.Alsoudi A, Copperman TS, Idowu OO, Kersten RC. Occult nasolacrimal duct obstruction secondary to IgG4-related ophthalmic disease. Ophthalmic Plastic Reconstructive Surger. 2019;35:E62–E64. doi: 10.1097/IOP.0000000000001345. [DOI] [PubMed] [Google Scholar]
- 53.Erdei A, Steiber Z, Molnar C, Berenyi E, Nagy EV. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy. BMC Ophthalmol. 2018;18:5. doi: 10.1186/s12886-018-0672-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Ginat DT, Freitag SK, Kieff D, Grove A, Fay A, Cunnane M, Moonis G. Radiographic patterns of orbital involvement in igg4-related disease. Ophthalmic Plastic Reconstructive Surg. 2013;29:261–266. doi: 10.1097/IOP.0b013e31829165ad. [DOI] [PubMed] [Google Scholar]
- 55.Hardy TG, McNab AA, Rose GE. Enlargement of the infraorbital nerve: an important sign associated with orbital reactive lymphoid hyperplasia or immunoglobulin G4-related disease. Ophthalmology. 2014;121:1297–1303. doi: 10.1016/j.ophtha.2013.12.028. [DOI] [PubMed] [Google Scholar]
- 56.Inaba H, Hayakawa T, Miyamoto W, Takeshima K, Yamaoka H, Furukawa Y, Kawashima H, Ariyasu H, Wakasaki H, Furuta H, Nishi M, Nakao T, Sasaki H, Okada Y, Matsunaga K, Nakamura Y, Akamizu T. IgG4-related ocular adnexal disease mimicking thyroid-associated orbitopathy. Internal Med. 2013;52:2545–2551. doi: 10.2169/internalmedicine.52.0902. [DOI] [PubMed] [Google Scholar]
- 57.Cheng S, Vu P. Recurrent orbital myositis with radiological feature mimicking thyroid eye disease in a patient with Crohn's disease. Orbit. 2009;28:368–370. doi: 10.3109/01676830903104751. [DOI] [PubMed] [Google Scholar]
- 58.Ishihara R, Jain SF, Perry D, Reinhardt A, Suh D, Legge R (2020) Orbital pseudotumor as the presenting symptom of Crohn's disease in a male child. American J Ophthalmol Case Reports 18. 10.1016/j.ajoc.2020.100669 [DOI] [PMC free article] [PubMed]
- 59.Ramalho J, Castillo M. Imaging of orbital myositis in Crohn's disease. Clinical Imaging. 2008;32:227–229. doi: 10.1016/j.clinimag.2007.09.012. [DOI] [PubMed] [Google Scholar]
- 60.Mehta D, Tabbaa M. Rare ocular manifestation of IBD. American J Gastroenterol. 2016;111:S813–S814. doi: 10.1038/ajg.2016.370. [DOI] [Google Scholar]
- 61.Zenone T. Orbital myositis and Crohn's disease. Inter J Rheumatic Diseases. 2014;17:481–482. doi: 10.1111/1756-185X.12238. [DOI] [PubMed] [Google Scholar]
- 62.Mavrikakis I, Rootman J. Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol. 2007;144:769–775. doi: 10.1016/j.ajo.2007.07.019. [DOI] [PubMed] [Google Scholar]
- 63.Malik R, Plant GT. Sarcoid orbital myositis. Neuro-Ophthalmol. 1999;22:227–231. doi: 10.1076/noph.22.4.227.3716. [DOI] [Google Scholar]
- 64.Campagna G, Prospero Ponce CM, Vickers A, Hong BYB, Pellegrini F, Cirone D, Romano F, Machin P, Lee AG 2020 Neuro-ophthalmic sarcoidosis. Neuro-Ophthalmol 44: 319–326. 10.1080/01658107.2019.1583761 [DOI] [PMC free article] [PubMed]
- 65.Kim JS, Scawn RL, Lee BW, Lin JH, Korn BS, Kikkawa DO. Masquerading orbital sarcoidosis with isolated extraocular muscle involvement. Open Ophthalmol J. 2016;10:140–145. doi: 10.2174/1874364101610010140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hayashi Y, Ishii Y, Nagasawa J, Arai S, Okada H, Ohmi F, Umetsu T, Machida Y, Kurasawa K, Takemasa A, Suzuki S, Senoh T, Sada T, Hirata K. Subacute sarcoid myositis with ocular muscle involvement; a case report and review of the literature. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33:297–301. [PubMed] [Google Scholar]
- 67.Boddu N, Jumani M, Wadhwa V, Bajaj G, Faas F 2017 Not all orbitopathy is Graves': Discussion of cases and review of literature. Front Endocrinology 8. 10.3389/fendo.2017.00184 [DOI] [PMC free article] [PubMed]
- 68.Simon EM, Zoarski GH, Rothman MI, Numaguchi Y, Zagardo MT, Mathis JM. Systemic sarcoidosis with bilateral orbital involvement: MR findings. Am J Neuroradiol. 1998;19:336–337. [PMC free article] [PubMed] [Google Scholar]
- 69.Ismailova DS, Abramova JV, Novikov PI, Grusha YO. Clinical features of different orbital manifestations of granulomatosis with polyangiitis. Graefes Arch Clin Exp Ophthalmol. 2018;256:1751–1756. doi: 10.1007/s00417-018-4014-9. [DOI] [PubMed] [Google Scholar]
- 70.Bahrami B, Juniat V, Davis G, Selva D. Pachymeningeal enhancement on magnetic resonance imaging in granulomatosis with polyangiitis. Can J Ophthalmol. 2020;55:e181–e182. doi: 10.1016/j.jcjo.2020.04.005. [DOI] [PubMed] [Google Scholar]
- 71.Franco J, Lee NG 2020 Granulomatosis with polyangiitis presenting as recurrent, multifocal orbital myositis. Orbit (London). 10.1080/01676830.2020.1817949 [DOI] [PubMed]
- 72.Salam A, Meligonis G, Malhotra R. Superior oblique myositis as an early feature of orbital Wegener's granulomatosis. Orbit. 2008;27:203–206. doi: 10.1080/01676830701854268. [DOI] [PubMed] [Google Scholar]
- 73.Lefebvre DR, Reinshagen KL, Yoon MK, Stone JH, Stagner AM. Case 39–2018: An 18-Year-Old Man with Diplopia and Proptosis of the Left Eye. N Engl J Med. 2018;379:2452–2461. doi: 10.1056/NEJMcpc1807503. [DOI] [PubMed] [Google Scholar]
- 74.Franco J, Lee NG 2020 Granulomatosis with polyangiitis presenting as recurrent, multifocal orbital myositis. Orbit: 1–3 10.1080/01676830.2020.1817949 [DOI] [PubMed]
- 75.Savino G, Midena G, Tartaglione T, Milonia L, Caputo CG, Grimaldi G. Clinical-radiological patterns and histopathological outcomes in non-thyroid extraocular muscle enlargement: retrospective case series and current concepts. Ophthalmic Plast Reconstr Surg. 2020;36:284–291. doi: 10.1097/iop.0000000000001533. [DOI] [PubMed] [Google Scholar]
- 76.Tsironi E, Eftaxias B, Karabatsas CH, Ioachim E, Kalogeropoulos C, Psilas K. An unusually longstanding, strictly ocular, limited form of Wegener's granulomatosis. Acta Ophthalmol Scand. 2005;83:123–125. doi: 10.1111/j.1600-0420.2004.00333.x. [DOI] [PubMed] [Google Scholar]
- 77.Arrico L, Abbouda A, Bianchi S, Malagola R. Acute monolateral proptosis and orbital myositis in a patient with discoid lupus erythematosus: a case report. J Med Case Rep. 2014;8:375. doi: 10.1186/1752-1947-8-375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Kono S, Takashima H, Suzuki D, Terada T, Konishi T, Miyajima H. Orbital myositis associated with discoid lupus erythematosus. Lupus. 2014;23:220–222. doi: 10.1177/0961203313517156. [DOI] [PubMed] [Google Scholar]
- 79.Selva D, Dolman PJ, Rootman J. Orbital granulomatous giant cell myositis: a case report and review. Clin Experimental Ophthalmol. 2000;28:65–68. doi: 10.1046/j.1442-9071.2000.00273.x. [DOI] [PubMed] [Google Scholar]
- 80.Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, Allen RC, Devoto MH, Harris GJ, Bernardini FP, Bonavolonta G, Codere F, Cockerham KP, Cruz AAV, Dutton JJ, Garrity JA, Goldberg RA, Grove AS, Kazim M, Kennerdell JS, Kersten RC, Kim YD, Levine MR, Lucarelli MJ, Mourits MP, Nerad JA, Orcutt JC, Perry JD, Putterman AM, Seah LL, Selva D, Sivak-Callcott JA, Stefanyszyn MA, Strianese D, Sullivan TJ, Verity D. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified delphi approach. JAMA Ophthalmology. 2017;135:769–776. doi: 10.1001/jamaophthalmol.2017.1581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Klein BR, Hedges Iii TR, Dayal Y, Adelman LS. Orbital myositis and giant cell myocarditis. Neurology. 1989;39:988–990. doi: 10.1212/WNL.39.7.988. [DOI] [PubMed] [Google Scholar]
- 82.Jui-Chi Chang R, Kuang V, Meyer J, Chang E, Roberts-Thomson SJ, McKelvie P, Hardy TG, Pick ZS 2020 Orbital giant cell myositis is an unusual and potentially lethal cause of bilateral ophthalmoplegia - a case report and literature review. Orbit: 1–7. 10.1080/01676830.2020.1856144 [DOI] [PubMed]
- 83.Caramaschi P, Biasi D, Carletto A, Bambara LM. Orbital myositis in a rheumatoid arthritis patient during etanercept treatment. Clin Exp Rheumatol. 2003;21:136–137. [PubMed] [Google Scholar]
- 84.Ssi-Yan-Kai I, Pearson A. Orbital myositis and psoriatic arthritis. Can J Ophthalmol. 2012;47:e42–43. doi: 10.1016/j.jcjo.2012.04.005. [DOI] [PubMed] [Google Scholar]
- 85.Spitzer SG, Bersani TA, Mejico LJ. Multiple bilateral extraocular muscle metastases as the initial manifestation of breast cancer. J neuro-ophthalmol : official j North American Neuro-Ophthalmol Soc. 2005;25:37–39. doi: 10.1097/00041327-200503000-00010. [DOI] [PubMed] [Google Scholar]
- 86.Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology. 2004;111:997–1008. doi: 10.1016/j.ophtha.2003.01.002. [DOI] [PubMed] [Google Scholar]
- 87.Watkins LM, Carter KD, Nerad JA. Ocular adnexal lymphoma of the extraocular muscles: case series from the University of Iowa and review of the literature. Ophthalmic plastic reconstructive surg. 2011;27:471–476. doi: 10.1097/IOP.0b013e31822e5c1b. [DOI] [PubMed] [Google Scholar]
- 88.Behbehani RS, Bilyk JR, Haber MM, Savino PJ. Orbital lymphoma with concomitant sarcoid-like granulomas. Ophthalmic Plast Reconstr Surg. 2005;21:458–461. doi: 10.1097/01.iop.0000186125.71845.03. [DOI] [PubMed] [Google Scholar]
- 89.Guo PD, Xian JF, Man FY, Liu ZH, Yan F, Zhao J, Wang ZC. Magnetic resonance imaging features of extraocular muscle lymphoma in five cases. Chinese med j. 2016;129:2384–2385. doi: 10.4103/0366-6999.190679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Izambart C, Robert PY, Petellat F, Petit B, Gastaud P, Lagier J, Labrousse F, Adenis JP. Extraocular muscle involvement in marginal zone B-cell lymphomas of the orbit. Orbit. 2008;27:345–349. doi: 10.1080/01676830802328469. [DOI] [PubMed] [Google Scholar]
- 91.Malik KJ, Berntson DG, Harrison AR. Lymphoplasmacytic lymphoma isolated to an extraocular muscle. Ophthal plastic reconstructive surg. 2006;22:400–401. doi: 10.1097/01.iop.0000235814.03599.72. [DOI] [PubMed] [Google Scholar]
- 92.Payne JF, Shields CL, Eagle RC, Jr, Shields JA. Orbital lymphoma simulating thyroid orbitopathy. Ophthal plastic reconstructive surg. 2006;22:302–304. doi: 10.1097/01.iop.0000225422.69538.17. [DOI] [PubMed] [Google Scholar]
- 93.Rossman D, Michel R, Codere F. A case of an enlarged medial rectus muscle. Inter ophthalmol. 2009;29:319–321. doi: 10.1007/s10792-008-9236-0. [DOI] [PubMed] [Google Scholar]
- 94.Stenman L, Persson M, Enlund F, Clasen-Linde E, Stenman G, Heegaard S. Primary orbital precursor t-cell lymphoblastic lymphoma: report of a unique case. Molecular and Clinical Oncology. 2016;5:593–595. doi: 10.3892/mco.2016.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Surov A, Behrmann C, Holzhausen HJ, Kösling S. Lymphomas and metastases of the extra-ocular musculature. Neuroradiology. 2011;53:909–916. doi: 10.1007/s00234-011-0873-z. [DOI] [PubMed] [Google Scholar]
- 96.Truong T, Char DH, Dillon WP. Superior oblique muscle neoplasms. Orbit. 1988;7:249–253. doi: 10.3109/01676838809052828. [DOI] [Google Scholar]
- 97.Shafi F, Mathewson P, Mehta P, Ahluwalia HS. The enlarged extraocular muscle: to relax, reflect or refer? Eye (Lond) 2017;31:537–544. doi: 10.1038/eye.2016.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Polito E, Galieni P, Leccisotti A. Bilateral optic nerve compression caused by lymphomatous infiltration of all extraocular muscles. Neuro-Ophthalmology. 1997;17:35–38. doi: 10.3109/01658109709009689. [DOI] [Google Scholar]
- 99.Kawakami H, Mochizuki K, Goto H, Watanabe N, Tanaka T 2017 Orbital T-cell lymphoma with discrete enlargements of all extraocular muscles bilaterally in patient with moon face countenance. Case reports in ophthalmological medicine 2017: 8902162. 10.1155/2017/8902162 [DOI] [PMC free article] [PubMed]
- 100.Jung JH, Oh EH, Shin DH, Choi SY, Choi KD, Choi JH. Orbital lymphoma presenting with inferior rectus palsy. J Clin Neurol (Korea) 2019;15:398–400. doi: 10.3988/jcn.2019.15.3.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Ejstrup R, Mikkelsen LH, Andersen MK, Clasen-Linde E, Gjerdrum LMR, Safavi S, Heegaard S. Orbital precursor B-lymphoblastic lymphoma involving the extraocular muscles in a 56-year-old male and a review of the literature. Oncology Lett. 2019;17:1477–1482. doi: 10.3892/ol.2018.9725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Hornblass A, Jakobiec FA, Reifler DM, Mines J. Orbital lymphoid tumors located predominantly within extraocular muscles. Ophthalmology. 1987;94:688–697. doi: 10.1016/s0161-6420(87)33393-7. [DOI] [PubMed] [Google Scholar]
- 103.Lacey B, Chang W, Rootman J (1999) Nonthyroid causes of extraocular muscle disease. Surv Ophthalmol 44: 187–213 10.1016/s0039-6257(99)00101-0 [DOI] [PubMed]
- 104.Framarino-Dei-Malatesta M, Chiarito A, Bianciardi F, Fiorelli M, Ligato A, Naso G, Pecorella I. Metastases to extraocular muscles from breast cancer: case report and up-to-date review of the literature. BMC cancer. 2019;19:36. doi: 10.1186/s12885-018-5253-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Wang Y, Mettu P, Maltry A, Harrison A, Mokhtarzadeh A (2017) Metastatic breast carcinoma to the superior oblique in a male. Ophthalmology and Therapy 6: 355–359. 10.1007/s40123-017-0093-7 [DOI] [PMC free article] [PubMed]
- 106.Choi JH, Park HJ, Choi KG, Lim KH, Park KD 2017 Unilateral ptosis with bilateral incomplete ophthalmoplegia as the initial presentation in metastatic cancer. EWHA Medical Journal 40: 136-139. 10.12771/emj.2017.40.3.136
- 107.Luneau K, Falardeau J, Hardy I, Boulos PR, Boghen D. Ophthalmoplegia and lid retraction with normal initial orbit CT imaging in extraocular muscle metastases as the presenting sign of breast carcinoma. Journal neuro-ophthalmol : official j North American Neuro-Ophthalmol Soc. 2007;27:144–146. doi: 10.1097/WNO.0b013e318064c3ee. [DOI] [PubMed] [Google Scholar]
- 108.Milman T, Pliner L, Langer PD. Breast carcinoma metastatic to the orbit: an unusually late presentation. Ophthalmic plastic reconstructive surg. 2008;24:480–482. doi: 10.1097/IOP.0b013e31818b6adc. [DOI] [PubMed] [Google Scholar]
- 109.Peckham EL, Giblen G, Kim AK, Sirdofsky MD. Bilateral extraocular muscle metastasis from primary breast cancer. Neurology. 2005;65:74. doi: 10.1212/01.Wnl.0000156359.93206.99. [DOI] [PubMed] [Google Scholar]
- 110.Polito E, Leccisotti A. Extraocular muscle enlargement as an isolated finding. A CT and MRI differential diagnosis. Orbit. 1993;12:31–42. doi: 10.3109/01676839309029881. [DOI] [Google Scholar]
- 111.Wiggins RE, Jr, Byrne SF. Metastatic tumor to the extraocular muscles: report of 5 cases. J AAPOS : official publ American Association Pediatric Ophthalmol Strabismus. 2012;16:489–491. doi: 10.1016/j.jaapos.2012.06.009. [DOI] [PubMed] [Google Scholar]
- 112.Yabaş Kızıloğlu Ö, Paksoy Türköz F, Totuk Gedar ÖM, Mestanoğlu M, Yapıcıer Ö. Breast Carcinoma Metastasis to the Medial Rectus Muscle: Case Report. Turkish j ophthalmol. 2019;49:168–170. doi: 10.4274/tjo.galenos.2018.39018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Coutinho I, Marques M, Almeida R, Custódio S, Silva TS, Águas F. Extraocular muscles involvement as the initial presentation in metastatic breast cancer. J Breast Cancer. 2018;21:339–342. doi: 10.4048/jbc.2018.21.e46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Salinas-Botrán A, Guarín-Corredor MJ. Orbital Metastasis in Breast Cancer. The New England j med. 2019;381:e26. doi: 10.1056/NEJMicm1814570. [DOI] [PubMed] [Google Scholar]
- 115.Greene DP, Shield DR, Shields CL, Shields JA, Servat JJ, Lin CJ, Douglass AM, Fulco EA, Levin F. Cutaneous melanoma metastatic to the orbit: review of 15 cases. Ophthal plastic reconstructive surg. 2014;30:233–237. doi: 10.1097/iop.0000000000000075. [DOI] [PubMed] [Google Scholar]
- 116.Krema H, Dawson LA, Hogg D, Laperriere N. Bilateral extraocular muscles metastases from a choroidal melanoma. Canadian j ophthalmol J canadien d'ophtalmologie. 2013;48:e74–76. doi: 10.1016/j.jcjo.2013.01.018. [DOI] [PubMed] [Google Scholar]
- 117.Capone A, Jr Slamovits TL 1990 Discrete metastasis of solid tumors to extraocular muscles. Archives of ophthalmology (Chicago, Ill : 1960) 108: 237–243. 10.1001/archopht.1990.01070040089037 [DOI] [PubMed]
- 118.Shih CY, Mirchandani G, Kazim M. Atypical MRI features of intraorbital metastatic melanoma. Ophthal plastic reconstructive surg. 2007;23:335–336. doi: 10.1097/IOP.0b013e318073cf85. [DOI] [PubMed] [Google Scholar]
- 119.Pirlamarla AK, Tang J, Amin B, Kabarriti R. Vulvar melanoma with isolated metastasis to the extraocular muscles: case report and brief literature review. Anticancer Res. 2018;38:3763–3766. doi: 10.21873/anticanres.12658. [DOI] [PubMed] [Google Scholar]
- 120.Gupta A, Chazen JL, Phillips CD. Carcinoid tumor metastases to the extraocular muscles: MR imaging and CT findings and review of the literature. AJNR Am J Neuroradiol. 2011;32:1208–1211. doi: 10.3174/ajnr.A2470. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Kamieniarz L, Armeni E, O'Mahony LF, Leigh C, Miah L, Narayan A, Bhatt A, Cox N, Mandair D, Navalkissoor S, Caplin M, Toumpanakis C. Orbital metastases from neuroendocrine neoplasms: clinical implications and outcomes. Endocrine. 2020;67:485–493. doi: 10.1007/s12020-019-02130-5. [DOI] [PubMed] [Google Scholar]
- 122.Ryan TG, Juniat V, Stewart C, Malhotra R, Hardy TG, McNab AA, Davis G, Selva D 2021 Clinico-radiological findings of neuroendocrine tumour metastases to the orbit. Orbit: 1–9. 10.1080/01676830.2021.1895845 [DOI] [PubMed]
- 123.Bohman E, Sahlin S, Seregard S. Carcinoid presenting as extrinsic eye muscle metastasis. Acta Ophthalmol. 2009;87:916–917. doi: 10.1111/j.1755-3768.2008.01470.x. [DOI] [PubMed] [Google Scholar]
- 124.Khaw P, Ball D, Duchesne G. Carcinoid tumour of the orbital muscles: a rare occurrence. Australasian radiol. 2001;45:179–181. doi: 10.1046/j.1440-1673.2001.00899.x. [DOI] [PubMed] [Google Scholar]
- 125.Kiratli H, Yilmaz PT, Yildiz ZI. Metastatic atypical carcinoid tumor of the inferior rectus muscle. Ophthal plastic reconstructive surg. 2008;24:482–484. doi: 10.1097/IOP.0b013e31818b6d02. [DOI] [PubMed] [Google Scholar]
- 126.Matsuo T, Ichimura K, Tanaka T, Takenaka T, Nakayama T (2010) Neuroendocrine tumor (carcinoid) metastatic to orbital extraocular muscle: case report and literature review. Strabismus 18: 123-128. 10.3109/09273972.2010.525779 [DOI] [PubMed]
- 127.Borota OC, Kloster R, Lindal S. Carcinoid tumour metastatic to the orbit with infiltration to the extraocular orbital muscle. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2005;113:135–139. doi: 10.1111/j.1600-0463.2005.apm1130207.x. [DOI] [PubMed] [Google Scholar]
- 128.Hatsis AJ, Henry RK, Curtis MT, Bilyk JR, Sivalingam MD, Eagle RC, Milman T 2020 Ocular adnexal manifestations of neuroendocrine neoplasms: a case report and a major review. Orbit: 1–11. 10.1080/01676830.2020.1839108 [DOI] [PubMed]
- 129.Sivagnanavel V, Riordan-Eva P, Jarosz J, Portmann B, Buxton-Thomas M. Bilateral orbital metastases from a neuroendocrine tumor. J Neuro-ophthalmol : Official J North American Neuro-Ophthalmol Soc. 2004;24:240–242. doi: 10.1097/00041327-200409000-00013. [DOI] [PubMed] [Google Scholar]
- 130.Kozubowska K, Skorek A, Pęksa R. Neuroendocrine tumour metastasis to the orbit. Endokrynologia Polska. 2019;70:455–456. doi: 10.5603/EP.a2019.0024. [DOI] [PubMed] [Google Scholar]
- 131.Lekse JM, Zhang J, Mawn LA. Metastatic gastroesophageal junction adenocarcinoma to the extraocular muscles. Ophthalmology. 2003;110:318–321. doi: 10.1016/s0161-6420(02)01559-2. [DOI] [PubMed] [Google Scholar]
- 132.Souayah N, Krivitskaya N, Lee HJ. Lateral rectus muscle metastasis as the initial manifestation of gastric cancer. J Neuro-ophthalmol : official J North American Neuro-Ophthalmol Soc. 2008;28:240–241. doi: 10.1097/WNO.0b013e318177253a. [DOI] [PubMed] [Google Scholar]
- 133.Goto S, Takeda H, Sasahara Y, Takanashi I, Yamashita H. Metastasis of advanced gastric cancer to the extraocular muscle: a case report. J Med Case Rep. 2019;13:107. doi: 10.1186/s13256-019-2031-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Julve M, Maviki M, Gillmore R 2014 Bilateral extraocular muscle (EOM) metastases from adenocarcinoma of the gastro-oesophageal junction (GOJ). BMJ case reports 2014. 10.1136/bcr-2014-205368 [DOI] [PMC free article] [PubMed]
- 135.Dodd MU, Wolkow N, Cunnane ME, Ma L, Dryja TP, Hunter D. Isolated orbital amyloidosis causing internal and external ophthalmoplegia. J aapos. 2020;24:48–51.e41. doi: 10.1016/j.jaapos.2019.11.003. [DOI] [PubMed] [Google Scholar]
- 136.Paula JS, Paula SA, Cruz AA, Chahud F. Superior oblique muscle amyloidosis mimicking myositis. Ophthalmic Plast Reconstr Surg. 2008;24:77–79. doi: 10.1097/IOP.0b013e31816102dd. [DOI] [PubMed] [Google Scholar]
- 137.Katz B, Leja S, Melles RB, Press GA. Amyloid ophthalmoplegia. Ophthalmoparesis secondary to primary systemic amyloidosis. J Clin Neuroophthalmol. 1989;9:39–42. [PubMed] [Google Scholar]
- 138.Tong JY, Juniat V, McKelvie PA, O'Donnell BA, Hardy TG, McNab AA, Selva D 2021 Clinical and radiological features of intramuscular orbital amyloidosis: a case series and literature review. Ophthalmic Plast Reconstr Surg. 10.1097/iop.0000000000002061 [DOI] [PubMed]
- 139.Okamoto K, Ito J, Emura I, Kawasaki T, Furusawa T, Sakai K, Tokiguchi S. Focal orbital amyloidosis presenting as rectus muscle enlargement: CT and MR findings. AJNR Am J Neuroradiol. 1998;19:1799–1801. [PMC free article] [PubMed] [Google Scholar]
- 140.Nishikawa N, Kawaguchi Y, Konno A, Kitani Y, Takei H, Yanagi Y. Primary isolated amyloidosis in the extraocular muscle as a rare cause of ophthalmoplegia: a case report and literature review. Am J Ophthalmol Case Rep. 2021;22:101052. doi: 10.1016/j.ajoc.2021.101052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Shah VS, Cavuoto KM, Capo H, Grace SF, Dubovy SR, Schatz NJ. Systemic amyloidosis and extraocular muscle deposition. J Neuroophthalmol. 2016;36:167–173. doi: 10.1097/wno.0000000000000358. [DOI] [PubMed] [Google Scholar]
- 142.Monteiro ML, Gonçalves AC, Bezerra AM. Isolated primary amyloidosis of the inferior rectus muscle mimicking Graves' orbitopathy. Einstein (Sao Paulo) 2016;14:553–556. doi: 10.1590/s1679-45082016rc3744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Li Y, Wang Y, Zhang W. A case of isolated amyloidosis in extraocular muscle mimicking thyroid eye disease. J aapos. 2020;24:122–124. doi: 10.1016/j.jaapos.2019.12.009. [DOI] [PubMed] [Google Scholar]
- 144.Murdoch IE, Sullivan TJ, Moseley I, Hawkins PN, Pepys MB, Tan SY, Garner A, Wright JE. Primary localised amyloidosis of the orbit. Br J Ophthalmol. 1996;80:1083–1086. doi: 10.1136/bjo.80.12.1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Chakrabortty S, Nagashima T, Izawa I, Sekiya Y, Sugiura T, Inoue M, Imai Y, Ehara K, Tamaki N. Intraorbital arteriovenous malformation: case report. Surg Neurol. 1993;40:320–325. doi: 10.1016/0090-3019(93)90144-p. [DOI] [PubMed] [Google Scholar]
- 146.Kamboj A, Tooley AA, Godfrey KJ, Maher MD, Schubert HD, Kazim M (2020) Extraocular muscle enlargement in retinoencephalofacial angiomatosis. Orbit 39: 221-223. 10.1080/01676830.2019.1677727 [DOI] [PubMed]
- 147.Patrinely JR, Osborn AG, Anderson RL, Whiting AS. Computed tomographic features of nonthyroid extraocular muscle enlargement. Ophthalmology. 1989;96:1038–1047. doi: 10.1016/s0161-6420(89)32785-0. [DOI] [PubMed] [Google Scholar]
- 148.Ahmadi J, Teal JS, Segall HD, Zee CS, Han JS, Becker TS. Computed tomography of carotid-cavernous fistula. AJNR Am J Neuroradiol. 1983;4:131–136. [PMC free article] [PubMed] [Google Scholar]
- 149.Kim D, Choi YJ, Song Y, Chung SR, Baek JH, Lee JH. Thin-section MR imaging for carotid cavernous fistula. American Journal of Neuroradiology. 2020;41:1599–1605. doi: 10.3174/ajnr.A6757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Komiyama M, Fu Y, Yagura H, Yasui T, Hakuba A, Nishimura S. MR imaging of dural AV fistulas at the cavernous sinus. J Comput Assist Tomogr. 1990;14:397–401. doi: 10.1097/00004728-199005000-00015. [DOI] [PubMed] [Google Scholar]
- 151.Chan HHL, Hardy TG, McNab AA. Spontaneous orbital hemorrhage related to the extraocular muscles. Ophthalmic Plast Reconstr Surg. 2019;35:256–261. doi: 10.1097/iop.0000000000001223. [DOI] [PubMed] [Google Scholar]
- 152.Ben Simon GJ, McNab AA. Idiopathic orbital hemorrhage related to the inferior rectus muscle: a rare cause for acute-onset diplopia and unilateral proptosis. Ophthalmology. 2005;112:1838–1843. doi: 10.1016/j.ophtha.2005.04.019. [DOI] [PubMed] [Google Scholar]
- 153.Landau Prat D, Greenberg G, McNab AA, Ben Simon G. Nontraumatic Orbital Hemorrhage (NTOH) In: Ben Simon G, Greenberg G, Landau Prat D, editors. Atlas of Orbital Imaging. Cham: Springer International Publishing; 2022. pp. 683–693. [Google Scholar]
- 154.Hakin KN, McNab AA, Sullivan TJ. Spontaneous hemorrhage within the rectus muscle. Ophthalmology. 1994;101:1631–1634. doi: 10.1016/s0161-6420(94)31126-2. [DOI] [PubMed] [Google Scholar]
- 155.Sundaram PM, Jayakumar N, Noronha V. Extraocular muscle cysticercosis - a clinical challenge to the ophthalmologists. Orbit. 2004;23:255–262. doi: 10.1080/01676830590889866. [DOI] [PubMed] [Google Scholar]
- 156.Rath S, Honavar SG, Naik M, Anand R, Agarwal B, Krishnaiah S, Sekhar GC. Orbital cysticercosis clinical manifestations, diagnosis, management, and outcome. Ophthalmology. 2010;117(600–605):605.e601. doi: 10.1016/j.ophtha.2009.07.030. [DOI] [PubMed] [Google Scholar]
- 157.Sekhar GC, Honavar SG. Myocysticercosis: experience with imaging and therapy. Ophthalmology. 1999;106:2336–2340. doi: 10.1016/s0161-6420(99)90537-7. [DOI] [PubMed] [Google Scholar]
- 158.Ding J, Zhao H, Lin J. Surgical excision of orbital cysticercosis lodged in superior oblique muscle: clinical case report. Medicine (Baltimore) 2015;94:e1026. doi: 10.1097/md.0000000000001026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Shashni A, Pujari A, Bajaj MS, Kumar P. Superior oblique muscle cysticercosis: importance of long-term assessment by a single observer. Can J Ophthalmol. 2018;53:e193–e195. doi: 10.1016/j.jcjo.2017.11.007. [DOI] [PubMed] [Google Scholar]
- 160.Labh RK, Sharma AK. Ptosis: a rare presentation of ocular cysticercosis. Nepal J Ophthalmol. 2013;5:133–135. doi: 10.3126/nepjoph.v5i1.7842. [DOI] [PubMed] [Google Scholar]
- 161.Chopra R, Kapoor H, Chopra A. Ocular myocysticercosis: favorable outcomes with early diagnosis and appropriate therapy. Nepal J Ophthalmol. 2012;4:315–318. doi: 10.3126/nepjoph.v4i2.6551. [DOI] [PubMed] [Google Scholar]
- 162.Agrawal S, Ranjan S, Mishra A (2013) Ocular myocysticercosis: an unusual case of ptosis. Nepal J Ophthalmol 5: 279–281. 10.3126/nepjoph.v5i2.8745 [DOI] [PubMed]
- 163.Saravi SS, Sabouni F, Arefidoust A, Yaftian R, Heydarzadeh S, Rajabi MT (2016) An orbital hydatid cyst involving inferior rectus muscle: a case report. Orbit 35: 109-112. 10.3109/01676830.2015.1099705 [DOI] [PubMed]
- 164.Acharya IG, Jethani J. Pyomyositis of extraocular muscle: case series and review of the literature. Indian J Ophthalmol. 2010;58:532–535. doi: 10.4103/0301-4738.71712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Chandraparnik P, Lumyongsatien M, Selva D (2021) Multifocal extraocular muscle pyomyositis: A case report and review of literature. Orbit 40: 258-262. 10.1080/01676830.2020.1768558 [DOI] [PubMed]
- 166.Varma A, Sharma K, Rathi B, Gupta RK, Malik V. Isolated abscess of extraocular muscle in two young boys: clinical and imaging features. Orbit. 2003;22:67–72. doi: 10.1076/orbi.22.1.67.14009. [DOI] [PubMed] [Google Scholar]
- 167.Haufschild T, Weber P, Nuttli I, Hecker B, Flammer J, Kaiser HJ. Idiopathic isolated abscess in an extraocular muscle in a child. Arch Ophthalmol. 2004;122:1233–1234. doi: 10.1001/archopht.122.8.1233. [DOI] [PubMed] [Google Scholar]
- 168.Agius MdB, Vella M. A rare case of an idiopathic extraocular muscle abscess. Malta Med J. 2015;27:34–37. [Google Scholar]
- 169.Mombaerts I, Rose GE, Verity DH. Diagnosis of enlarged extraocular muscles: when and how to biopsy. Curr Opin Ophthalmol. 2017;28:514–521. doi: 10.1097/icu.0000000000000395. [DOI] [PubMed] [Google Scholar]
- 170.Jyani R, Ranade D, Joshi P. Spectrum of orbital cellulitis on magnetic resonance imaging. Cureus. 2020;12:e9663. doi: 10.7759/cureus.9663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Tsirouki T, Dastiridou AI, Ibánez flores N, Cerpa JC, Moschos MM, Brazitikos P, Androudi S. Orbital cellulitis. Surv Ophthalmol. 2018;63:534–553. doi: 10.1016/j.survophthal.2017.12.001. [DOI] [PubMed] [Google Scholar]